文献速递免疫规划

三剂SARS-CoV-2 BNT162b2疫苗后抗体滴度的一年动态变化

One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine.
PubMed 文献 · Vaccine · 2022-12-21

本研究对免疫情景下接种三剂BNT162b2的医护人员进行前瞻性随访,排除既往SARS-CoV-2感染者,在六个预设时间点测量抗刺突抗体滴度至接种后一年(第三剂后4-6个月)。完成全部六次检测的76名医护人员中,第三剂后抗体滴度迅速显著升高,随后虽下降但在长达六个月内仍高于所有既往测量值。

要点

  • 76名完成全部六次检测的医护人员中,第三剂后抗体滴度迅速显著升高。
  • 抗体滴度随后下降,但长达六个月内仍高于所有既往测量值。
  • 第三剂BNT162b2可诱导深度的体液免疫应答。

核心结论

  • 第三剂BNT162b2可诱导深度的体液免疫应答,即使六个月后仍显著高于既往测量值。

研究设计与样本

  • 前瞻性研究,纳入接种三剂BNT162b2的免疫功能正常医护人员,排除有SARS-CoV-2感染史者,在六个预设时间点(从第二剂前至接种后一年,即第三剂后4-6个月)测量抗刺突抗体滴度。
  • 76名医护人员完成了全部六次血清学检测。

主要发现

  • 第三剂疫苗后抗体滴度迅速显著升高,随后下降,但长达六个月内仍高于所有既往测量值。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A third dose of the BNT162b2 SARS-CoV-2 vaccine leads to a significant increase in antibody levels, however, concerns regarding the long-term persistence of this response exist. We assessed the humoral response for one year following vaccination. METHODS: A prospective study among immunocompetent healthcare workers (HCW) who received three doses of BNT162b2. anti-spike antibody titers were measured at six predefined timepoints, from before the second vaccine dose, and up to one year afterwards, which is 4-6 months after the third dose. HCW with a history of SARS-CoV-2 infection were excluded. RESULTS: Seventy-six HCW had all the six serological measurements. Antibody titers significantly increased shortly following the third vaccine dose, and while declining, remained higher from all previous measurements for up to six months. CONCLUSIONS: A third dose of BNT162b2 leads to a profound humoral response, which remains significantly higher than previous measurements, even after 6 months.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wand O, Breslavsky A, Bar-Shai A, et al. One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine. Vaccine. 2022. PMID: 36566162. doi:10.1016/j.vaccine.2022.12.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。